It is still unknown which antiplatelet monotherapy should be continued after a period of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI).
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis
Francaviglia, Bruno;Capodanno, Davide;Capranzano, Piera
Ultimo
2022-01-01
Abstract
It is still unknown which antiplatelet monotherapy should be continued after a period of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
4.37 MB
Formato
Adobe PDF
|
4.37 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
